7Baggers

We provide you with 20 years of free, institutional-grade data for NPCE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NPCE. Explore the full financial landscape of NPCE stock.

Reported DateTickerType
2026-05-12NPCE10-QUrl
2026-03-03NPCE10-KUrl
2025-11-04NPCE10-QUrl
2025-08-12NPCE10-QUrl
2025-05-13NPCE10-QUrl
2025-03-04NPCE10-KUrl
2024-11-12NPCE10-QUrl
2024-08-13NPCE10-QUrl
2024-05-08NPCE10-QUrl
2024-03-05NPCE10-KUrl
2023-11-06NPCE10-QUrl
2023-08-08NPCE10-QUrl
2023-05-04NPCE10-QUrl
2023-03-02NPCE10-KUrl
2022-11-08NPCE10-QUrl
2022-08-11NPCE10-QUrl
2022-05-12NPCE10-QUrl
2022-03-10NPCE10-KUrl
2021-11-10NPCE10-QUrl
2021-08-12NPCE10-QUrl
2021-06-03NPCE10-QUrl
2021-03-24NPCES-1Url

NeuroPace Inc
(NASDAQ:NPCE) 

NPCE stock logo

Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially av...

Founded: 1997
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing

Share this website to your friends
The information provided in this report about NPCE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.